Publications Database

Posey D. J. et al. (2007)

Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures.

Biological Psychiatry

61(4), pp. 538-544.

Read Full (New Window)

Posey D. J. et al. (1999)

Risperidone in the treatment of two very young children with autism.

Journal of Child and Adolescent Psychopharmacology

9(4), pp. 273-276

Read Abstract (New Window)

Posey D. J. , McDougle C. J. (2000)

The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders.

Harvard Review of Psychiatry

8(2), pp. 45-63

Read Abstract (New Window)

Posey D. J. et al. (2006)

The use of selective serotonin reuptake inhibitors in autism and related disorders.

Journal of Child and Adolescent Psychopharmacology

16(1), pp. 181-186

Read Abstract (New Window)

Scahill L. et al. (2006)

A prospective open trial of guanfacine in children with pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 589-598.

Read Abstract (New Window) Read Full (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

11(4), pp. 377-388

Read Abstract (New Window)

Scahill L. et al. (2001)

Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism.

Journal of Child and Adolescent Psychopharmacology

Winter, 11(4), pp, 377-88.

Read Abstract (New Window)

Stigler K. A. et al. (2004)

A naturalistic retrospective analysis of psychostimulants in pervasive developmental disorders.

Journal of Child and Adolescent Psychopharmacology

14(1), pp. 49-56

Read Abstract (New Window)

Stigler K. A. et al. (2009)

Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study.

Journal of Child and Adolescent Psychopharmacology

19(3), pp. 265-274

Read Abstract (New Window) Read Full (New Window)

Stigler K. A. et al. (2009)

Autism and immune factors: A comprehensive review.

Research in Autism Spectrum Disorders

pp. 840-860

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2004)

Case report: aripiprazole for maladaptive behavior in pervasive developmental disorder.

Journal of Child and Adolescent Psychopharmacology

14(3), pp. 455-463

Read Abstract (New Window)

Stigler K. A. et al. (2010)

Paliperidone for irritability in autistic disorder.

Journal of Child and Adolescent Psychopharmacology

pp. 75-78

Read Extract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2006)

Ramelteon for insomnia in two youths with autistic disorder.

Journal of Child and Adolescent Psychopharmacology

16(5), pp. 631-636

Read Abstract (New Window)

Stigler K. A. , Posey D. J. , McDougle C. J. (2002)

Recent advances in the pharmacotherapy of autism.

Expert Review of Neurotherapeutics

2(4), pp. 499-510

Read Abstract (New Window)

Stigler K. A. et al. (2004)

Weight gain associated with atypical antipsychotic use in children and adolescents: prevalence, clinical relevance, and management.

Pediatric Drugs

6(1), pp. 33-44

Read Abstract (New Window)

Tierney E. et al. (2007)

Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study.

Psychopharmacology (Berl)

March, 191(1), pp. 149-157.

Read Abstract (New Window)

Vitiello B. et al. (2005)

Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone.

Journal of Clinical Psychopharmacology

25(6), pp. 565-569

Read Abstract (New Window)

Williams S. K. et al. (2006)

Risperidone and adaptive behavior in children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

45(4), pp. 431-439

Read Abstract (New Window) Read Full (New Window)

Wink L. K. et al. (2016)

A randomized placebo-controlled pilot study of N-acetylcysteine in youth with autism spectrum disorder.

Molecular Autism

7(26),

Read Full (New Window)

Wink L. K. et al. (2017)

d-Cycloserine enhances durability of social skills training in autism spectrum disorder.

Molecular Autism

Read Abstract (New Window) Read Full (New Window)